Integra LifeSciences
IART
IART
283 hedge funds and large institutions have $3.14B invested in Integra LifeSciences in 2023 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 87 increasing their positions, 104 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 261 → 283 (+22)
8.04% more ownership
Funds ownership: 84.33% → 92.36% (+8%)
16% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 104
Holders
283
Holding in Top 10
4
Calls
$548K
Puts
$296K
Top Buyers
| 1 | +$200M | |
| 2 | +$53.5M | |
| 3 | +$11.5M | |
| 4 |
PE
Point72 Europe
London,
United Kingdom
|
+$11.1M |
| 5 |
EIP
Easterly Investment Partners
Beverly,
Massachusetts
|
+$10.5M |
Top Sellers
| 1 | -$63.2M | |
| 2 | -$26M | |
| 3 | -$25.1M | |
| 4 |
ClearBridge Investments
New York
|
-$11.7M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$9.45M |